Liver Cancer Trial, Recruiting (NCT05143619)

Liver Cancer Trial, Recruiting NCT05143619 Sponsor: M.D. Anderson Cancer Center Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05143619 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Doctors who have completed their radiology residency training (not currently in training)
Radiologists who have specialized training in imaging of the abdomen, either currently undergoing or already completed
Radiologists who have experience reading liver scans, regardless of how many years they have been doing so
Radiologists working in any type of medical setting, such as university hospitals, community clinics, or government facilities
Radiologists practicing in any country in the world
Radiologists whether or not they are familiar with the standard guidelines used to diagnose liver cancer (called LI-RADS)
Radiologists who have an interest in education and/or teaching

Who may not be able to join:

Doctors who have not completed formal radiology training
Radiologists who do not have experience reading abdominal or liver scans
Doctors who are currently still completing their radiology residency training
Radiologists who do not have an interest in education and/or teaching

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Khaled M Elsayes, MD, M.D. Anderson Cancer Center

Phone: (713) 794-1191

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05143619

Sponsor: M.D. Anderson Cancer Center

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

Trial contact: (713) 794-1191

More information: https://clinicaltrials.gov/study/NCT05143619

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Doctors who have completed their radiology residency training (not currently in training)
Radiologists who have specialized training in imaging of the abdomen, either currently undergoing or already completed
Radiologists who have experience reading liver scans, regardless of how many years they have been doing so
Radiologists working in any type of medical setting, such as university hospitals, community clinics, or government facilities
Radiologists practicing in any country in the world
Radiologists whether or not they are familiar with the standard guidelines used to diagnose liver cancer (called LI-RADS)
Radiologists who have an interest in education and/or teaching

Who may not be able to join:

Doctors who have not completed formal radiology training
Radiologists who do not have experience reading abdominal or liver scans
Doctors who are currently still completing their radiology residency training
Radiologists who do not have an interest in education and/or teaching

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

M.D. Anderson Cancer Center

Registry

ClinicalTrials.gov

Start date

10 May 2019

Est. completion

2 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Teaching rates of the hepatocellular carcinoma diagnosis guidelines

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov